Skip to main content
. Author manuscript; available in PMC: 2011 Apr 15.
Published in final edited form as: Int J Cancer. 2010 Apr 15;126(8):1850–1860. doi: 10.1002/ijc.24964

Fig. 6.

Fig. 6

EGFRvIII enhances CXCR4 expression transcriptionally through the up-regulation of HIF-1α and post-translationally by increasing p38 MAPK activation and decreasing AIP4 and β-arrestin 1/2, leading to decreased CXCR4 internalization, cellular trafficking, and lysosomal degradation.